BMY

HOLD

Bristol-Myers Squibb Company

Healthcare · Rank #32 · Analyzed Apr 20, 2026

$60.17

Current Price

$318.02

Intrinsic Value

0.0%

Upside/Downside

10/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus2/3 methods agree

Quality Score3.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$7.25

Base (IV)$318.02

High$492.93

Entry Points

Conservative$7.25

Moderate$162.64

Aggressive$318.02

⚠️ Warnings

Upside capped: raw 719% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity40.4% → 1.0/1.0

Debt LevelD/E 255 → 0/1.0

Revenue QualityGrowth 0.0%, margin Δ-0.6% +recovery → 0.5/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins14.6% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.